The US Food and Drug Administration (FDA) has withdrawn its membership in the Global Harmonization Working Party (GHWP) that largely represents Asian regulators. The agency said it decided to leave the organization after being sidelined on key issues.
Cincinnati, OH – Collective intelligence is necessary for the creation of standards for artificial intelligence. That was the message Pat Baird, senior regulatory specialist at Philips brought to the AI Summit held by the AFDO/RAPS Healthcare Products Collaborative.
Interpol has arrested 72 people for selling millions of dollars' worth of counterfeit drugs in a global dragnet across 89 countries during Operation Pangea. The international law enforcement agency said they seized $7 million worth of drugs, more than closed 1,300 websites, and initiated 325 new investigations between 3-10 October.
MONTREAL – The regulatory professional of the future will need to embrace change and deeper collaboration at a faster pace and on a greater scale than previously seen, according to panelists at the opening plenary session of RAPS Convergence 2023.
The last few years have seen unprecedented change in regulatory affairs through the impacts of the COVID-19 pandemic, a transforming regulatory environment, anticipated and unanticipated delays, and other changes. This year's RAPS Convergence will focus on taking what regulators have learned from these changes to prepare for the future of the profession.
The International Medical Device Regulators Forum (IMDRF) released four final guidances this week that address cybersecurity best practices, verification and validation for personalized medical devices and post-market surveillance communication between regulators.